No Data
No Data
A-share immunotherapy concept pullback Guanhao Biotech fell more than 9%
Gelonghui, May 10 | Guanhao Biotech fell more than 9%, Chitianhua and Xiangxue Pharmaceuticals fell more than 7%, and Zhongyuan Xiehe and Tailin Biotech followed suit.
Chitianhua (600227.SH): A total of 2,921,000 shares have been repurchased
Gelonghui, May 6, 丨 Chitianhua (600227.SH) announced that as of April 30, 2024, the company had repurchased 2,921,100 shares, accounting for 0.1725% of the company's total share capital. The highest purchase price was 2.10 yuan/share, the lowest price was 1.74 yuan/share, and the total amount paid was 5,454,740 yuan.
ChiTianhua (600227.SH) announced first-quarter results with a net loss of 40.1807 million yuan
ChiTianhua (600227.SH) released its report for the first quarter of 2024. The company's revenue was 437 million yuan,...
Guizhou ChitianhuaLtd (SHSE:600227 Shareholders Incur Further Losses as Stock Declines 13% This Week, Taking Five-year Losses to 55%
Generally speaking long term investing is the way to go. But no-one is immune from buying too high. To wit, the Guizhou Chitianhua Co.,Ltd. (SHSE:600227) share price managed to fall 55% over five lo
Chatianhua (600227.SH): A total of 599,500 shares have been repurchased
Gelonghui, April 1, 丨 Chitianhua (600227.SH) announced that as of March 31, 2024, the company had repurchased a total of 599,500 shares, accounting for 0.035% of the company's total share capital. The highest purchase price was 2.10 yuan/share, the lowest price was 2.05 yuan/share, and the total amount paid was 1,249,395.00 yuan.
Express News | Chitianhua: Wholly-owned subsidiary Tongzi Chemical resumes production of methanol products
No Data